New drug limits and then repairs brain damage in stroke

Sunday, 27 November 2016 22:49
Minhera Elen
Minhera Elen

Zon Staff

Researchers at The University of Manchester have discovered that a potential new drug reduces the number of brain cells destroyed by stroke and then helps to repair the damage.

stroke

A reduction in blood flow to the brain caused by stroke is a major cause of death and disability, and there are few effective treatments.

A team of scientists at The University of Manchester has now found that a potential new stroke drug not only works in rodents by limiting the death of existing brain cells but also by promoting the birth of new neurones (so-called neurogenesis).

This finding provides further support for the development of this anti-inflammatory drug, interleukin-1 receptor antagonist (IL-1Ra in short), as a new treatment for stroke. The drug is already licensed for use in humans for some conditions, including rheumatoid arthritis. Several early stage clinical trials in stroke with IL-1Ra have already been completed in Manchester, though it is not yet licensed for this condition.

In the research, published in the biomedical journal Brain, Behavior and Immunity, the researchers show that in rodents with a stroke there is not only reduced brain damage early on after the stroke, but several days later increased numbers of new neurones, when treated with the anti-inflammatory drug IL-1Ra.

Previous attempts to find a drug to prevent brain damage after stroke have proved unsuccessful and this new research offers the possibility of a new treatment.

Importantly, the use of IL-1Ra might be better than other failed drugs in stroke as it not only limits the initial damage to brain cells, but also helps the brain repair itself long-term through the generation of new brain cells.

These new cells are thought to help restore function to areas of the brain damaged by the stroke. Earlier work by the same group showed that treatment with IL-1Ra does indeed help rodents regain motor skills that were initially lost after a stroke. Early stage clinical trials in stroke patients also suggest that IL-1Ra could be beneficial.

The current research is led by Professor Stuart Allan, who commented: "The results lend further strong support to the use of IL-1Ra in the treatment of stroke, however further large trials are necessary."

The paper, 'Reparative effects of interleukin-1 receptor antagonist in young and aged/co-morbid rodents after cerebral ischemia', was published in the journal Brain, Behavior and Immunity.

Source: http://medicalxpress.com/news/2016-11-drug-limits-brain.html

Video

El azar no tiene sentido, existe una fuerza inteligente que lo gobierna todo (DIOS)

Helen Cassan Dra   Science & Tech   04 February 2017

No lo digo yo sino el reputado físico teórico norteamericano Michio Kaku, famoso por formular la revolucionaria teoría de las…

Weekly hot post

YA ES OFICIAL: REVISTA CIENTÍFICA EUROPEA CONFIRMA QUE EL 9/11 FUE UNA DEMOLICIÓN CONTROLADA.

Helen Cassan Dra   Discovery   20 April 2017

15 años después de los atentados del 11 de septiembre, la Revista Científica Europea, del Instituto Científico Europeo (ESI), publicó…

Qi Gong Master Demonstrates “Chi” Energy in Extraordinary Footage.

Helen Cassan Dra   News   28 March 2017

Qi gong is an holistic system of carefully coordinated body movements, breathing activities, and meditation used to balance and improve…

ILLUMINATI'S GRAND WIZARD ABERT PIKE: 'WE WILL USE ISLAM TO SPARK WORLD WAR 3'

Helen Cassan Dra   News   28 March 2017

Albert Pike’s ‘sequence of three world wars prediction’ is of particular interest. Albert Pike was a top Illuminati Grand Wizard,…

CONSTANTINO: El emperador que INVENTÓ la religión CATÓLICA para controlar a todos

Helen Cassan Dra   News   26 March 2017

En 313 promulga El Edicto de Milán que despenalizó la práctica del cristianismo y se devolvieron las propiedades de la…

Amazing!!!

Jason Aiello   Quizzes   13 March 2017